Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NULL
  • 52 Week Low: 1.00p
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 0
  • Beta: 0.03

Key dates

Dividend  
Latest XD Date n/a
Latest Pay Date n/a
   
Meetings  
AGM 09-Jun-2025
EGM n/a
GMs 14-Jun-2024
   
Announcements  
Trading announcement 27-Feb-2025
IMSs n/a
Drilling Report n/a
   
Results  
Final results 08-May-2025
Interim results 04-Sep-2024
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 26-May-2023
   
Year End n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

POLX Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NULL
52 Week Low 1.00p
Volume 0
Shares Issued 1,207.03m
Beta 0.03

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

POLX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page